Together, these results map compartment-specific signatures of senescence and early neuropathology across the non-human primate (NHP) lifespan and support the use of NHP models in translational biomarker studies.
Abstract
Aging is the primary risk factor for neurodegenerative disease, yet the protein signatures that distinguish physiological brain aging from pathological decline remain incompletely defined in translational models. Using the targeted NULISAseq proteomic platform, we profiled cerebrospinal fluid (CSF) and plasma from 66 rhesus macaques (Macaca mulatta) spanning adult, pre-geriatric, and geriatric ages, and benchmarked the results against human reference samples. Age-related differences were broader and predominantly positive in plasma, whereas comparatively fewer CSF proteins differed with age. Canonical neurosenescence markers of axonal, astrocytic, and microglial biology, including neurofilaments, GFAP, and TREM2, showed age-related patterns similar to those reported in human aging. Synaptic and barrier proteins behaved differently by compartment: neuronal pentraxins and pleiotrophin were lower in the CSF of older animals, while choroid plexus proteins FOLR1 and IGFBP7 were lower in pre-geriatric animals. While immunohistochemistry confirmed extensive parenchymal amyloid deposition in geriatric brains alongside sparse tau pathology, plasma amyloid-beta and phosphorylated tau species tracked age and cortical amyloid burden more closely than their CSF counterparts. Systemic inflammatory and metabolic stress proteins, including IL6 and GDF15, were higher in older animals, resembling human inflammaging. Finally, we describe a subclustering of geriatric animals based on CSF proteomic signatures that is not explained by chronological age. Together, these results map compartment-specific signatures of senescence and early neuropathology across the non-human primate (NHP) lifespan and support the use of NHP models in translational biomarker studies.
Results demonstrate distinct systemic and renal molecular remodeling during feline aging and highlight the utility of integrated omics analyses of biological fluids for identifying molecular alterations relevant to both feline and human aging.
Punyatoya Panda, Rodrigo Mohallem, Rita de Kassia Rodrigues Bezerra Filgueira et al.· Journal of Proteome Research· 0 citations
Abstract INTRODUCTION Elevated cerebrospinal fluid (CSF) inflammatory proteins have been reported in Alzheimer's disease (AD), yet whether they reflect peripheral immune cell infiltration or central nervous system (CNS)–intrinsic pathological processes remains unclear. We tested whether AD exhibits a distinct CSF prote...
Sina Zaic, T. König, O. Keritam et al.· Alzheimer's & Dementia· 0 citations
Tau pathology is a defining feature of several neurodegenerative disorders, but reusable proteomic resources from non-human primate tauopathy models remain limited. Here we describe a four-dimensional label-free quantitative proteomic dataset from cortex and spinal cord tissues of wild-type and Tau-P301L transgenic c...
Brain aging is a major risk factor for cerebrovascular and neurodegenerative diseases, yet continuous cell-type changes across the human lifespan remain incompletely defined. Here, we integrate 15 prefrontal cortex (PFC) snRNA-seq datasets from 158 neurologically healthy donors (19–101 years) to construct an atlas of...
Rui-Ze Niu, Meng-Yuan Zhang, Zhi-Lan Yang et al.· npj Aging· 0 citations
Abstract Recent studies show that serum glial fibrillary acidic protein (GFAP) is highest in healthy infancy and early childhood and then declines steadily with age, while plasma tau protein phosphorylated at position 217 is strikingly elevated in healthy newborns and can exceed values observed in Alzheimer’s disease (...
L. Pini, M. Margoni, Massimo Filippi et al.· Brain Communications· 0 citations
INTRODUCTION Alzheimer’s disease (AD) displays pronounced sex differences, with women exhibiting greater prevalence and pathological burden than men. However, the molecular mechanisms underlying these differences remain elusive. Translation of preclinical findings to human AD remains challenging, potentially due to lim...
Jillian E. J. Cox, Ewa Poljańska, Sarah Ray et al.· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.